Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermacyd Tina Gel Sweet Flower is a specialized intimate hygiene product developed by Sanofi's consumer healthcare division. Formulated as a topical gel, its primary active components are lactic acid and lactoserum (whey), which are designed to mimic and support the natural protective environment of the female intimate area. The mechanism of action involves maintaining a physiological acidic pH, which is essential for the stability of the local microbiota and the prevention of dysbiosis. By reinforcing the acid mantle, the product helps inhibit the colonization and proliferation of pathogenic bacteria and fungi. The "D-Sanofi" designation is associated with clinical safety evaluations, such as compatibility studies, which assess the product's potential for dermal irritability and sensitization across various skin phototypes to ensure high tolerability for daily use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dermacyd Tina Gel Sweet Flower.